Advenica: Filling the pipeline
Research update Q1 2026
|2026-04-29
- Multi-year contracts of MSEK 300 announced in April
- Lower product sales in Q1
- We adjust our fair value to SEK 23 (18) per share
Advenica's Q1-report showed disappointing product sales, leading to a lukewarm quarter as a whole. Revenue landed at MSEK 39 versus MSEK 58 a year ago. Despite the report not being too exciting, the contracts entered in April certainly are. The company secured over MSEK 300 in multi-year contracts with Swedish authorities, including its largest deal ever at MSEK 230. New product launches have also broadened the portfolio. We increase our revenue forecasts leading to a revised fair value of SEK 23 per share.
Read our latest research update below.